about
The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cellsVitamin D in inflammatory diseases.The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration.Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.Immunogenetics of ageing.New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta.Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model.Anti-inflammatory activity of anti-hyperlipidemic drug, fenofibrate, and its phase-I metabolite fenofibric acid: in silico, in vitro, and in vivo studies.Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells.
P2860
Q28485319-27C7D706-F72E-482A-AA5B-FB4F1625C1FBQ33833563-FF050DE9-3A48-47B3-A5FC-7168B2F56E30Q34636574-0F986369-F169-4774-9CF3-90CC1BC66B29Q35693003-FDF50D9F-BB06-452A-B7B2-73C07B5C1756Q35893380-78E31BFA-BB2D-4BBE-A80B-608FD8E24AEBQ36054090-0E2AE810-88F5-4A30-BA28-CDBFEA4F850EQ36816270-57650792-9869-4C08-AF5C-410F2FE968A4Q37395283-E5661D8E-35C9-4F75-A015-2143D2DD01AEQ37897290-9002D208-4CE5-420B-B3F6-0232C4FA22A1Q39138216-3CA2D64A-4B30-456A-B4A9-2F3A35756D9DQ40185516-C5F5AC09-A409-4935-BA84-3D7D6439FD2BQ42589673-DC26D394-2E53-46FF-88EB-3FF94D7C5351Q44932855-958EE3D2-8517-4D6E-9600-651ED7FE6EEAQ47099413-AD7C7688-7FFD-4043-9BBA-9A8AA3021180Q49853377-EE723BD6-B938-48D2-911C-EA98DEA748CEQ54635145-9C41C765-189B-4706-ABB8-9B5B1AE06CF4
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
COX-2 and atherosclerosis.
@ast
COX-2 and atherosclerosis.
@en
type
label
COX-2 and atherosclerosis.
@ast
COX-2 and atherosclerosis.
@en
prefLabel
COX-2 and atherosclerosis.
@ast
COX-2 and atherosclerosis.
@en
P1476
COX-2 and atherosclerosis
@en
P2093
Maria Luigia Fazia
P304
P356
10.1097/00005344-200605001-00006
P407
P478
47 Suppl 1
P577
2006-01-01T00:00:00Z